ANDA 40713, held by Kvk Tech. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40713 (Promethazine Hydrochloride), held by Kvk Tech, was first approved by FDA on Jul 31, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride50MG ยท tablet;oral | Promethazine Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters